No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Why Intensity Therapeutics (INTS) Stock Is Getting Hammered
Wall Street Set to Open Lower Friday Amid Slew of Earnings Reports
Investors Parse Earnings Reports as US Futures Dip in Fridays Premarket
Intensity Therapeutics, Inc. Announces $2.35 Million Public Offering
Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results
Intensity Therapeutics Highlights Cancer Treatment Progress